Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Shannon

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Blood|December 18, 2010
Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locusQing Li, Kevin M Haigis, Andrew McDaniel, et al.
JCI Insight|September 8, 2023
Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activationPan-Yu Chen, Benjamin J Huang, Max Harris, et al.
Human Mutation|November 6, 2007
Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutationEllen Denayer, Annabel Parret, Magdalena Chmara, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Acute Myeloid Leukemia Relapse after Bromodomain Inhibitor Treatment or Chemotherapy is Characterized by Myc-Ras Transcriptional RemodelingBenjamin J Huang, Jeevitha D'Souza, Alexa Rane Batingana, et al.
Cancer Discovery|June 5, 2013
Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformationJin Xu, Kevin M Haigis, Ari J Firestone, et al.
Cardiology in the Young|June 8, 2022
Transseptal puncture during catheter ablation associated with higher radiation exposureMaryam Rahman, Grace Smith, Chris Johnsrude, et al.
Leukemia|March 5, 2024
5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignanciesJasmine C Wong, Kelley M Weinfurtner, Tamara Westover, et al.
Cancer Research|January 5, 2011
Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant miceJean L Nakamura, Connie Phong, Emile Pinarbasi, et al.
Blood|November 2, 2014
Preclinical efficacy of MEK inhibition in Nras-mutant AMLMichael R Burgess, Eugene Hwang, Ari J Firestone, et al.
Blood|March 18, 2010
Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignanciesJasmine C Y Wong, Yan Zhang, Kenneth H Lieuw, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Blood|December 18, 2010
Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locusQing Li, Kevin M Haigis, Andrew McDaniel, et al.
JCI Insight|September 8, 2023
Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activationPan-Yu Chen, Benjamin J Huang, Max Harris, et al.
Human Mutation|November 6, 2007
Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutationEllen Denayer, Annabel Parret, Magdalena Chmara, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Acute Myeloid Leukemia Relapse after Bromodomain Inhibitor Treatment or Chemotherapy is Characterized by Myc-Ras Transcriptional RemodelingBenjamin J Huang, Jeevitha D'Souza, Alexa Rane Batingana, et al.
Cancer Discovery|June 5, 2013
Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformationJin Xu, Kevin M Haigis, Ari J Firestone, et al.
Cardiology in the Young|June 8, 2022
Transseptal puncture during catheter ablation associated with higher radiation exposureMaryam Rahman, Grace Smith, Chris Johnsrude, et al.
Leukemia|March 5, 2024
5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignanciesJasmine C Wong, Kelley M Weinfurtner, Tamara Westover, et al.
Cancer Research|January 5, 2011
Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant miceJean L Nakamura, Connie Phong, Emile Pinarbasi, et al.
Blood|November 2, 2014
Preclinical efficacy of MEK inhibition in Nras-mutant AMLMichael R Burgess, Eugene Hwang, Ari J Firestone, et al.
Blood|March 18, 2010
Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignanciesJasmine C Y Wong, Yan Zhang, Kenneth H Lieuw, et al.
Pageof 12